Recent studies show the FDA is now exploring GLP-1s as a potential medication-assisted treatment for addiction
Semaglutide typically increases resting heart rate by 2 to 3 BPM , while retatrutide increases it by 5 to 10 BPM
[1] [2] However, the published data do not provide detailed week-by-week fatigue timelines, and retatrutide-specific evidence on the precise duration of tiredness remains limited
The Sequence That Works at Our Miami Clinic When facial volume loss has already occurred, treatment sequencing matters
Among these, liraglutide in the LEADER study, semaglutide in the SUSTAIN-6, albiglutide in the Harmony Outcomes, dulaglutide in the REWIND, and efpeglenatide in the AMPLITUDE-O exhibited significant beneficial effects on 3-point major adverse cardiac events (3P-MACE: death from CV disease, non-fatal myocardial infarction, and non-fatal stroke), the primary end point of each study, compared to the placebo group, respectively
This 48-week, dose-ranging study enrolled adults with obesity and evaluated multiple dose levels of retatrutide against placebo